Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nomination Committee’s proposal for the Board ahead of the 2017 Annual General Meeting of Svenska Cellulosa Aktiebolaget SCA

The Nomination Committee of Svenska Cellulosa Aktiebolaget SCA proposes the re-election of board members Ewa Björling, Pär Boman, Maija-Liisa Friman, Annemarie Gardshol, Magnus Groth, Bert Nordberg, Louise Svanberg, Johan Malmquist and Barbara Milian Thoralfsson. The Nomination Committee proposes that Lars Rebien Sørensen be elected as a new Board member. In addition, the Nomination Committee proposes that Pär Boman be re-elected as Chairman of the Board. Information about the Board members nominated for re-election is available on SCA’s website.Lars Rebien Sørensen, B.Sc. Forestry and B.Sc.

United Bankers Oyj: SHARE REPURCHASE 23.2.2017

United Bankers Oyj     STOCK EXCHANGE ANNOUNCEMENT    23.2.2017     SHARE REPURCHASE 23.2.2017   In the Helsinki Stock Exchange     Trade date 23.2.2017Bourse trade BUYShare UNIAVAmount 75 sharesAverage price/ share 35.9000 EURTotal cost 2 692,50 EUR  United bankers Oyj now holds a total of 7 437 shares including the shares repurchased on 23.2.2017.     On behalf of United Bankers Oyj   Nordea Bank AB (publ), Finnish Branch Janne Sarvikivi         Julius

Placing of shares in Capio AB (publ)

Press release, 23 February 2017 NOT FOR DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SINGAPORE, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL This announcement is not an offer to sell or a solicitation to buy securities in any jurisdiction, including the United States, Australia, New Zealand, South Africa, Hong Kong, Singapore, Canada and Japan. Neither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection

Badger Explorer ASA – Q4 2016 Report

Badger Explorer ASA (BXPL) releases its Q4 2016 Report today. The Company's Q4 2016 investor presentation can be accessed via dial-in teleconference on Friday, 24th February 2017 at 08:30 - 09:30 CET. For participation please dial +47 21 98 42 00 and enter the access code 24 06 16 04. For alternative dial-in numbers, please visit www.globafy.com/free-conference-call/ BXPL secured new equity in the two Private Placements of NOK 345 million in total during Q4 2016 and Q1 2017 with the Subsequent Offerings of up to NOK 50 million. The new funding enables to ramp up the Badger Explorer

Patrick Demarchelier legendary fashion photographer now at Fotografiska with Lumière

Lumière Patrick Demarchelier at Fotografiska February 24 – May 14 World famous, respected and highly appreciated fashion photographer exhibits at Fotografiska with Lumière February 24 – May 14. ”Show me the light – and it makes me tick”, says this charming, ever curious legend, who regards his models as artists, and who is always waiting for his best photograph to come… For Patrick Demarchelier, photography is not a profession – it is a passion. – I just love it. Everything about it. Every day is an adventure and it doesn’t matter if it’s about fashion, portraits or personal

SCA invests to further strengthen tissue operations in Mexico and baby diaper operations in Europe

To further strengthen competitiveness and enable future growth in the tissue operations in Mexico, SCA has decided to invest about USD 105m (approx. SEK 950m) in one of the company’s facilities in the country. To strengthen its baby diaper product offering in Europe, SCA has also decided to invest about EUR 40m (approx. SEK 380m) in facilities in Europe.The investment in Mexico will support SCA’s high-quality tissue offering under the Regio brand. The investment is aligned with the company’s strategy to streamline production and secure capacity for future growth in order to increase value

Charlotte Mecklenburg Library shares FAQs for Morrison Renovation

Morrison Regional Library Renovation Frequently Asked Questions1. Why are you renovating the library?As a much loved and much used building that has been in use for almost 25 years, Morrison needs updated building systems including electrical, HVAC, mechanical, fire protection and telecommunications. At the same time, the renovation provides a chance to rethink the building spaces based on community feedback and 21st century practices. We are grateful for Mecklenburg County for approval of the funding in 2014. 2. Will the library be closed during the renovation? For how long?Yes,

CORRECTION: Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions, February 23, 2017 at 5:30 pm local time (EET) CORRECTION TO BIOHIT OYJ – MANAGER’S TRANSACTIONS IN FEBRUARY 23, 2017 AT 3:50 PM LOCAL TIME (EET) Transaction details should read as follows: Transaction Details (1): Volume: 13933 Unit price: 3,40920 EUR (2): Volume: 2776 Unit price: 3,70400 EUR (3): Volume: 15299 Unit price: 3,51260 EUR (4): Volume: 3962 Unit price: 3,51260 EUR   Aggregated transactions (4): Volume: 35970 Volume weighted average price: 3.48732 EUR   The release including the corrected information is

Episurf Medical AB (publ) publishes prospectus; Episurf’s former CEO’s incentive programmes terminated

The prospectus regarding the rights issue in Episurf Medical AB (publ) (“Episurf” or the “Company”) has been approved and registered by the Swedish Financial Supervisory Authority and is now available on the Company’s website (www.episurf.com). On 18 January 2017, the Board of Directors of Episurf resolved on an up to approximately SEK 120 million new issue of A and B shares with preferential rights for shareholders, subject to subsequent approval of an extraordinary general meeting. The extraordinary general meeting held on 20 February 2017 resolved to approve the resolution of the

Proposed distribution of SCA’s hygiene business - An information brochure will be published in the week beginning March 6, 2017

In August 2016, SCA announced that the company would initiate work in order to be able to propose to the 2017 Annual General Meeting to decide on a split of the SCA Group into two listed companies; one to operate the hygiene business and one to operate the forest products business. In addition to a proposed cash dividend of SEK 6.00 per share, SCA’s Board of Directors has today decided to propose to the Annual General Meeting on April 5, 2017 to decide on the distribution of all shares in the wholly owned subsidiary SCA Hygiene AB to shareholders of SCA. Additional information to SCA’s

Cybercom buys digital agency Duplicera in Sundsvall

IT consultancy Cybercom is expanding its operations in the north of Sweden by acquiring Sundsvall agency Duplicera as an investment to enhance its position in digital solutions in the region.“We have a strong team in Sundsvall that delivers services to companies throughout Sweden. Duplicera is one of the trendsetting digital agencies in southern Norrland, and has expertise in e-commerce and digital marketing that complements us well,” says Johan Stenborg, head of Cybercom’s operations in Sundsvall.  Duplicera, which was founded in 2007, focuses on graphic design, web production, digital

#17-177 Listing of Mini futures issued by SG Issuer

As from February 24, 2017, 14 Mini futures issued by SG Issuer will be listed on NDX Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB. Issuer: SG Issuer Type of security: Mini futures, open ended Execution: Automatic cash settlement Term: As from February 24, 2017 and forward or until time for knock out event Market Maker: Societe Generale Underlying: AstraZeneca PLC Boliden AB Telefonaktiebolaget LM Ericsson ser. B Nordea Bank AB (SEK) OMXS30 index Current values of strike and barrier can be

Oxeon AB invests €3million to increase their ±45° TeXtreme® spread tow weaving capacity

Since its introduction, Oxeon’s ±45° version of TeXtreme® has been a gamechanger for those seeking a continuous ±45° spread tow fabric.  Due to the increased demand, Oxeon is proud to announce an investment of €3 million to expand their patented ±45° Spread Tow weaving capacity.Known for its ability to reduce weight, increase stiffness and strength, improve impact protection as well as improve dampening performance in thin plies, TeXtreme® Spread Tow Fabrics extend these benefits found in its 0°/90° fabrics to its ±45°continuous length fabrics which are available in widths up to 60”/1.5m.

ABB invests in Enbala Power Networks to co-develop cutting-edge grid software

Zurich, Switzerland, February 23, 2017 - Next-generation software solutions will enhance ABB AbilityTM by giving grid operators control over the growing number of distributed energy resourcesABB announced today it has invested in Enbala Power Networks, a leading developer of software for managing power distribution networks. The investment was made through ABB’s venture capital unit, ABB Technology Ventures. Today’s grid operators require digital solutions to deal with challenges posed by the increasing amount of intermittent renewable and distributed energy sources being integrated into

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions, February 23, 2017 at 4:00 pm local time (EET) ____________________________________________   Person subject to the notification requirement Name: Korpela, Semi Position: Chief Executive Officer Issuer: Biohit Oyj LEI: 74370089ATTSNBXJVT29   Notification type: INITIAL NOTIFICATION Reference number: 74370089ATTSNBXJVT29_20170223130533_5 ____________________________________________   Transaction date: 2017-02-20 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT

Sedana Medical AB (publ) registers AnaConDa in South Korea

Sedana Medical AB’s (publ) (“Sedana Medical” or " the Company") product AnaConDa is approved by K-FDA in South Korea. South Korea is the first country in Asia to approve AnaConDa. The product will be launched in cooperation with the distributor DaeSeuk Med Co. Ltd.AnaConDa received approval from the South Korean authority K-FDA on 23 February 2017, making South Korea the first market in Asia to approve the AnaConDa technology. Sedana Medical had previously signed a contract with the South Korean distributor DaeSeuk Med Co. Ltd. concerning the rights to market and sell AnaConDa to South

Badger Explorer ASA - Mandatory Notification of Trade

Reference is made to the EGM in Badger Explorer ASA ("the Company") on 23rd February 2017, where the share capital increase in connection with the Private Placement of 600,000,000 new shares in the Company (the "Private Placement") was approved, as well as the Subsequent Offering of up to 80,000,000 new shares in the Company that commenced on 15th February 2017 and expires on 27th February 2017 (the "Subsequent Offering"). This disclosure is made in accordance with Section 4-3 of the Norwegian Securities Trading Act. As a result of the completion of the Private Placement, the ownership

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions, February 23, 2017 at 3:55 pm local time (EET) ____________________________________________   Person subject to the notification requirement Name: Korpela, Semi Position: Chief Executive Officer Issuer: Biohit Oyj LEI: 74370089ATTSNBXJVT29   Notification type: INITIAL NOTIFICATION Reference number: 74370089ATTSNBXJVT29_20170223130523_7 ____________________________________________   Transaction date: 2017-02-20 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions, February 23, 2017 at 3:50 pm local time (EET) ____________________________________________   Person subject to the notification requirement Name: Korpela, Semi Position: Chief Executive Officer Issuer: Biohit Oyj LEI: 74370089ATTSNBXJVT29   Notification type: INITIAL NOTIFICATION Reference number: 74370089ATTSNBXJVT29_20170223141702_5 ____________________________________________   Transaction date: 2017-02-20 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions, February 23, 2017 at 3:45 pm local time (EET) ____________________________________________   Person subject to the notification requirement Name: Hendolin, Panu Position: Other senior manager Issuer: Biohit Oyj LEI: 74370089ATTSNBXJVT29   Notification type: INITIAL NOTIFICATION Reference number: 74370089ATTSNBXJVT29_20170223130128_6 ____________________________________________   Transaction date: 2017-02-20 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT

Notice to attend and extraordinary shareholders’ meeting in Cherry AB (publ)

The shareholders of Cherry AB, reg. no. 556210-9909, (the ”Company”), are hereby given notice to attend an extraordinary shareholders’ meeting to be held Monday 13 March 2017 at 10.00 a.m. at Advokatfirman Delphi’s office, with address Mäster Samuelsgatan 17, 7th floor, Stockholm. Registration for the meeting commences at 09.30 a.m. Right to participate Shareholders who wish to participate at the extraordinary shareholders’ meeting must: -          be entered in the share register kept by Euroclear Sweden AB on Tuesday 7 March 2017, and -          give notice of attendance to

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions, February 23, 2017 at 3:40 pm local time (EET) ____________________________________________   Person subject to the notification requirement Name: Hendolin, Panu Position: Other senior manager Issuer: Biohit Oyj LEI: 74370089ATTSNBXJVT29   Notification type: INITIAL NOTIFICATION Reference number: 74370089ATTSNBXJVT29_20170223122815_6 ____________________________________________   Transaction date: 2017-02-20 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions, February 23, 2017 at 3:35 pm local time (EET) ____________________________________________   Person subject to the notification requirement Name: Hendolin, Panu Position: Other senior manager Issuer: Biohit Oyj LEI: 74370089ATTSNBXJVT29   Notification type: INITIAL NOTIFICATION Reference number: 74370089ATTSNBXJVT29_20170223122604_2 ____________________________________________   Transaction date: 2017-02-20 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT

Per Ekdunge is appointed new CEO of PowerCell Germany GmbH

The leading Nordic fuel cell company PowerCell Sweden AB (publ)  wants to strengthen its presence at the German market, and has appointed Per Ekdunge as new CEO of the German subsidiary PowerCell Germany GmbH. With thirty years of experience in fuel cells and the German market, Per Ekdunge has a well-developed network in the industry.Germany is at the forefront of renewable energy. Since 2015, PowerCell Sweden AB (publ) has a German subsidiary, and announces now that Per Ekdunge is appointed as the new CEO of PowerCell Germany GmbH as of March 1, 2017. The current

There are no items matching the current filter
There are no more items matching the current filter
Back to top